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Ethyl acetate, chloroform, butanol and methanol extracts of the aerial parts of Conyza Canadensis L. 
Cronquist were investigated for their antiviral activity against human cytomegalovirus (HCMV) AD-169 
and Cox-B3 viruses by modification of the widely used shell-vial assay. The results showed that butanol 
and methanol extracts had the most potent antiviral activity against HCMV and Cox-B3 viruses. 
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Herbal medicine represents one of the most important 
fields of traditional medicine all over the world. There has 
been growing interest in the investigation of natural 
products from plants for the discovery of new 
antimicrobial agents. The appearance of viral resistant 
strains to antiviral agents is an emerging problem. Thus, 
the prevalence of viral related diseases is of great 
concern. For this reason, the development of new and 
better antiviral compounds is vital and desirable. It has 
been demonstrated that natural products are preferable 
to synthetic compounds as sources of new antiviral 
agents (Vanden et al., 1986; Vlietinck and Vanden, 1991; 
Abad et al., 1997). A number of compounds with 
inhibitory activity against the replication of several viruses 
have been extracted from a number of medicinal plants 
(De Rodriguez et al., 1990, 1996; Marchetti et al., 1996; 
Hayashi et al., 1997). Conyza canadensis (L.) Cronquist 
belongs to the family of Compositae and is native to 
North America (Weaver, 2001). This plant also grows 
spontaneously in central Tunisia. Whole plant has been 
used as a Tunisian folk medicine for the treatment of    
rheumatism. It also has antidiarrhoeal and antiha-
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Sastri, 1952). In our previous work, we reported that C. 
canadensis extracts possess antibacterial and antioxidant 
activities (Edziri et al., 2008). 
In searching for natural products as potential antiviral 
agents, we have examined the antiviral action of C. 
canadensis L. Cronquist extracts against human 
cytomegalovirus (HCMV) and Coxsackie B3 viruses. 
 
 
MATERIALS AND METHODS 
 
Plant material was collected in the flowering season from Monastir 
region (Tunisia). The plant was identified by Doctor Mohamed 
Chaieb, a botanist in the University of Science (Sfax, Tunisia). A 






Powdered plant tissues (700 g) were extracted three times by 
maceration with methanol, the resultant extract was concentrated 
under reduced pressure. The methanol extract was extracted 
successively with equal volumes of four organic solvents of 
increasing polarity of petroleum ether, chloroform, ethyl acetate and 
butanol. The different extracts were concentrated to dryness and 





Human  diploid  embryonic  lung  fibroblasts  (MRC-5)  (Biomerieux- 




Table 1. Cytotoxic activity of Conyza 







Petroleum ether 250 














France) were grown in MEM-D (Seromed, Germany, Ref. T041-05) 
supplemented with 100 units/ml penicillin, 100 mcg/ml streptomycin 
and 10% fetal calf serum (FCS Ref. S0115, Seromed, Germany). 
FCS was reduced to 2% for the viral infection.  
 
 
MTT assay  
 
The MTT colorimetric assay was performed in 96-well plates 
(Polydoro et al., 2004). Briefly, each well of a 96-well plate (NUNC, 
Ref. 167008) contained a continuous monolayer of MRC-5 cells at 
a concentration of 10
5
 cells/well. After that, the medium was 
removed and various concentrations of each extract were added. 
After 48 h, the extract was eliminated, the cells were washed twice 
with phosphate buffer saline and 15 ml of a 5 mg/ml solution of 
MTT (3-dimethylthiazol-yl)-2 and 5-diphenyltetrazolium bromide 
(Sigma M5655) was added. The plate was covered with self-
adhesive tape and incubated at 37°C for 2 h. After incubation, the 
MTT solution was removed and 50 µl dimethyl sulfoxide (DMSO) 
was added to dissolve insoluble formazan crystal. The absorbance 
was read in a microplate reader (Reader 530, Organon Teknika) at 
570 nm. CC50 parameter is defined as the concentration (µg/ml) of 
substrate that causes 50% death of cells. 
 
 
Titration of viruses 
 
HCMV strain AD-169 (ATCC Ref. VR 538) and Coxsackie B virus 





) were prepared in MEM-D containing 2% 
FCS, were inoculated into confluent cells in quadruplicate wells of 
96-well plates and incubated at 37°C in a humidified atmosphere 
containing 5% CO2 for 3 to 5 days. When a cytopathic effect (CPE) 
in the virus-infected cells was observed microscopically, virus titers 
were expressed as 50% tissue culture-infective dose (TCID50) and 
were determined by the method of Reed and Muench (1938). The 
mouse monoclonal antibodies directed against the immediate-early 
CMV 76 kD antigen (clone E-13, Ref. 11-003, ARGENA-Biosoft, 
France) was diluted 1:50 in PBS. The same source provided the 





The mouse monoclonal antibodies directed against the immediate-
early CMV 76 kD antigen and Cox-B3 (clone E-13, Ref. 11-003, 





source provided the goat-anti-mouse FITC-conjugated antibody 
(Ref. 50-012). This antibody was diluted 1:100 in PBS-supple-
mented with 0.002% Evan’s blue. 
 
 
Antiviral activity  
 
The test used in this paper is a modification of the generally used 
‘shell-vial’ culture method for the early detection of the CMV 
infection (Alpert et al., 1985). The diagnostic method was sensitive 
(Pepin et al., 1991) and quantitative (Mazeron et al., 1991). Extracts 
of the plant were diluted in MEM-D, then the virus was added, and 
centrifuged for 1 h at 1000 g. After centrifugation, the wells were 
incubated for 48 h at 37°C, and the viral antigens were revealed by 
immunofluorescence.  
The culture medium was aspirated and the cells were infected 
with 600 µl of the virus dilution followed by centrifugation at 1000 g 
for 1 h. After centrifugation, the mixture was incubated for 48 h at 
37°C, and then the viral antigens were revealed by immuno-
fluorescence.  
The immunofluorescence detection of the viral antigens was 
common for the earlier mentioned procedures and was as follows: 
at the end of incubation, the content of the wells was aspirated and 
the cells were fixed with cold methanol at 20°C for 10 min. The 
methanol was aspirated and 250 µl of anti immediate-early antibody 
was added and incubated for 45 min at 37°C in a humidified 
chamber. At the end of this time, the wells were washed three times 
for 5 min with PBS. Then the FITC labelled anti-mouse antibody 
was incubated for 40 min and finally washed under the same 
conditions three times as previously done. After that, the cells were 
observed under an immunofluorescence microscope. Because the 
extracts were dissolved in dimethylsulphoxide (DMSO) which 
positively affects the infectivity of the viruses (Li and Fong, 1990), 
DMSO was also included in the wells without any extract. The 
antiviral activity was determined by counting the number of cells 
infected by the virus (presenting fluorescent nuclei) in comparison 
with the number of infected cells in the reference well (no presence 
of any antiviral agent). The reference well contained cells infected 
by the virus without any antiviral agent. The earlier described 
experiments were done three to four times. 
 
 
RESULTS AND DISCUSSION 
 
The results of the MTT assay are presented in Table 1 
and show that all extracts of C. Canadensis were not 
cytotoxic against MRC5 cells (CC50 is above 250 µg/ml). 
The results of the antiviral activity are presented in Table 
2. As shown in this table, ethyl acetate, chloroform, 
butanol and methanol extracts had anti-HCMV and anti-
Cox-B3 activity but the most active extract seemed to be 
methanol extract (Table 2). The active concentration of 
the methanol extract was 100 µg/ml with 99% activity 
against CMV virus and 100% activity against Cox-B3 
virus. 
To our knowledge, this study represents the first 
demonstration of an inhibitory activity of C. canadensis 
extracts against the CMV and Cox-B3 viruses. Many 
studies have shown the antiviral action of the plant or its 
constituents: hypericin and pseudohypericin on different 
viruses. Human CMV is a frequent cause of infection in 
immunocompromised people. The available anti-CMV 
drugs are not very effective in some patients and/or safe. 
Drug resistance is also a growing problem.  Coxsackie B- 









Antiviral activity (%) 
HCMV CoxB-3 
Petroleum ether 
200 nd nd 
100 nd nd 
    
Ethyl acetate 
200 80.12 75 
100 78.65 60 
    
chloroform 
200 87.54 78 
100 75.98 75 
    
Butanol 
200 95.75 99 
100 90.10 97 
    
Methanol 
200 100.0 100 
100 99.10 100 
    
Ganciclovir 0.8 50 - 
    




3 viruses are single-strand positive-sense RNA viruses 
that are resistant to a wide variety of chemical treat-
ments. 
Since HCMV is a very slow growing virus, we 
attempted the modified ‘shell-vial’ diagnostic method to 
reduce the culture time to 48 h, in this way limiting most 
of the inconvenient artefacts induced by a long culture 
step. This method is quantitative as the number of 
positive nuclei is directly proportional to the number of 
viruses growing.  
The most active extract seemed to be methanol with 
active concentration of 100 µg/ml which also had no 
cytotoxic effect against MRC-5 cells. The ED50 of 
ganciclovir against a laboratory strain of CMV, AD-169 
was 0.8 mg/ml (Tocci et al., 1984). Thus, for the current 
investigation, it is obvious that the methanol extract of C. 
canadensis had a potent anti-HCMV action on the 
laboratory strain AD-169 and anti-Cox B3 virus. 
Screening of chemical groups in the methanolic extract of 
C. canadensis (L.) Cronquist revealed the presence of 
flavonoids, terpenoids and tannins. The observed 
antiviral activity may be due to the higher amount of 
phenolic compounds, particularly flavonoids and tannins 
which are known to possess good antiviral activities 
(Fukuchi et al., 1989; Namba et al., 1998). However, it is 
difficult at the moment to indicate the exact mode of this 
action, which requires further examination. It is concluded 
that C. canadensis could contain one or more products 
and almost non-cytotoxic compounds, showing a strong 
antiviral activity. Further studies are in progress with the 
aim of understanding the exact mechanism of action of 
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